The most common tumour types where Signatera is already routinely used are:
Breast cancer
Colon cancer
Lung cancer
Pancreatic cancer
Stomach cancer
Esophageal cancer
Ovarian cancer
Endometrial tumour
Neuroendocrine tumours
Melanoma
Sarcoma
Kidney cancer
The Signatera test cannot be used in the following cases:
In synchronous primary tumours*
In case of pregnancy
In patients who have had a previous (non-autologous) bone marrow transplant
In patients who have had a blood transfusion in the last 3 months
In non-solid tumours, eg.: haematological malignancies
For brain tumors
* Inquire from our colleagues